Earnings Bonanza: Exclusive Stock Alert Inside!

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Beyond AI Stocks: The Rare Element Crucial To Modern Tech]( [Read this stunning report on a potential "tech" investment strategy]( --------------------------------------------------------------- February 8, 2024 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Where AI And Mining Intersect - Overlooked Connection Revealed]( the AI "arms race" continues to heat up, a new report shines a light on just how reliant modern technology is on precious metals. This report connects the dots between global superpowers, AI dominance, and an unassuming patch of Nevada desert that could change the game as we know it. [Learn how a young US company fits into the global AI race.]( --------------------------------------------------------------- [Anebulo Pharmaceuticals, Inc.]( Symbol: [ANEB]( Recent Price: $2.57 Average Analyst Price Target: $6.67 (159.40%) Market Cap: $65.88M Last Year's EPS: $-0.1 Consensus EPS Forecast: $-0.11 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: Michael Okunewitch, analyst at Maxim Group, reiterates coverage on [Anebulo Pharmaceuticals, Inc. (ANEB)]( in the Healthcare sector with a Buy rating and a price target of $6 (2 months ago). [TipRanks.com]( also reports that [Anebulo Pharmaceuticals, Inc.]( currently has 3 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $6.67 . The target pricing ranges from a high forecast of $8 down to a low forecast of $6. [Anebulo Pharmaceuticals, Inc. (ANEB)](’s last closing price was $2.57 which would put the average price target at 159.40% upside. Here are 3rd party ratings for [ANEB](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 40% (99 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [Essent Group Ltd.]( Symbol: [ESNT]( Recent Price: $53.14 Average Analyst Price Target: $57.20 (7.64%) Market Cap: $5.67B Last Year's EPS: $1.61 Consensus EPS Forecast: $1.57 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: Terry Ma, analyst at Barclays, reiterates coverage on [Essent Group Ltd. (ESNT)]( in the Financial Services sector with a Hold rating and a price target of $63 (4 weeks ago). [TipRanks.com]( also reports that [Essent Group Ltd.]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $57.20 . The target pricing ranges from a high forecast of $63 down to a low forecast of $54. [Essent Group Ltd. (ESNT)](’s last closing price was $53.14 which would put the average price target at 7.64% upside. Here are 3rd party ratings for [ESNT](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Top 14% (36 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Mr. Cooper Group Inc.]( Symbol: [COOP]( Recent Price: $67.66 Average Analyst Price Target: $80.50 (18.98%) Market Cap: $4.37B Last Year's EPS: $1.66 Consensus EPS Forecast: $1.73 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: Eric Hagen, analyst at BTIG, reiterates coverage on [Mr. Cooper Group Inc. (COOP)]( in the Financial Services sector with a Hold rating (1 week ago). [TipRanks.com]( also reports that [Mr. Cooper Group Inc.]( currently has 4 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $80.50 . The target pricing ranges from a high forecast of $88 down to a low forecast of $73. [Mr. Cooper Group Inc. (COOP)](’s last closing price was $67.66 which would put the average price target at 18.98% upside. Here are 3rd party ratings for [COOP](: - TipRanks.com: Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 27% (183 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Is Your Money - and Privacy - at Risk?]( digital dollar could be a major threat to both your money and your personal privacy. See how it might impact your financial freedom and data security – and what you can do to protect both. Be informed, stay ahead. [Protect Your Financial Privacy Now]( --------------------------------------------------------------- [Embecta Corp.]( Symbol: [EMBC]( Recent Price: $17.46 Average Analyst Price Target: $16.50 (-5.50%) Market Cap: $1.00B Last Year's EPS: $0.59 Consensus EPS Forecast: $0.45 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: Kallum Titchmarsh, analyst at Morgan Stanley, reiterates coverage on [Embecta Corp. (EMBC)]( in the Healthcare sector with a Sell rating and a price target of $16 (2 months ago). [TipRanks.com]( also reports that [Embecta Corp.]( currently has 2 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $16.50 . The target pricing ranges from a high forecast of $17 down to a low forecast of $16. [Embecta Corp. (EMBC)](’s last closing price was $17.46 which would put the average price target at -5.50% upside. Here are 3rd party ratings for [EMBC](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 32% (169 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [PepsiCo, Inc.]( Symbol: [PEP]( Recent Price: $171.47 Average Analyst Price Target: $185.00 (7.89%) Market Cap: $235.75B Last Year's EPS: $2.25 Consensus EPS Forecast: $1.72 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: Nik Modi, analyst at RBC Capital, reiterates coverage on [PepsiCo, Inc. (PEP)]( in the Consumer Defensive sector with a Hold rating and a price target of $180 (1 day ago). [TipRanks.com]( also reports that [PepsiCo, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $185.00 . The target pricing ranges from a high forecast of $210 down to a low forecast of $172. [PepsiCo, Inc. (PEP)](’s last closing price was $171.47 which would put the average price target at 7.89% upside. Here are 3rd party ratings for [PEP](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 22% (54 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Best way to buy gold today (not what you'd think)]( so many strange events happening across the economy (longest bear market for bonds since Civil War... unprecedented bank closures... and soaring prices) – it's no wonder the richest investors are loading up on gold. But what you might not realize is there's a much better way to profit from rising gold prices – without ever touching an ETF, mining stock, or even bullion. [Full details here.]( --------------------------------------------------------------- [Magna International Inc.]( Symbol: [MGA]( Recent Price: $58.53 Average Analyst Price Target: $65.60 (12.08%) Market Cap: $16.76B Last Year's EPS: $1.5 Consensus EPS Forecast: $1.33 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: Tamy Chen, analyst at BMO Capital, reiterates coverage on [Magna International Inc. (MGA)]( in the Consumer Cyclical sector with a Buy rating and a price target of $67 (1 week ago). [TipRanks.com]( also reports that [Magna International Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $65.60 . The target pricing ranges from a high forecast of $77 down to a low forecast of $60. [Magna International Inc. (MGA)](’s last closing price was $58.53 which would put the average price target at 12.08% upside. Here are 3rd party ratings for [MGA](: - TipRanks.com: Hold - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Sell, Top 44% (110 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [ImmunoGen, Inc.]( Symbol: [IMGN]( Recent Price: $29.55 Average Analyst Price Target: $31.07 (5.13%) Market Cap: $8.25B Last Year's EPS: $-0.02 Consensus EPS Forecast: $0.04462 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: John Newman, analyst at Canaccord Genuity, reiterates coverage on [ImmunoGen, Inc. (IMGN)]( in the Healthcare sector with a Hold rating and a price target of $31.26 (2 months ago). [TipRanks.com]( also reports that [ImmunoGen, Inc.]( currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $31.07 . The target pricing ranges from a high forecast of $31.26 down to a low forecast of $31. [ImmunoGen, Inc. (IMGN)](’s last closing price was $29.55 which would put the average price target at 5.13% upside. Here are 3rd party ratings for [IMGN](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Strong Buy, Top 37% (92 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Is this AI's biggest breakthrough to date?]( the past year, AI has amazed us all with its achievements. It can predict weather, recommend winning stocks, create original art, write computer code, detect skin cancer – and, shockingly, it can do all these things better than most humans. But when you see its latest leap (revealed in on-location footage), you may want to pinch yourself! [Get the full scoop here]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketMoverAlerts.com Disclaimer This email/newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this email/newsletter is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this email/newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our email/newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. [If you are not a human, click here.]( By opening and/or clicking on any link contained within this email, you are reconfirming your opt-in status. You can unsubsubscribe at any time by clicking on the link in the footer. MarketMoverAlerts.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software